Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

sertraline or amitriptyline

PreclinicalSmall molecule

GGerman Research Foundation

sertraline or amitriptyline is one of 2 small molecule programs targeting Depressed. It is currently in Preclinical.

1

Indications

1

Total Trials

0

Active Trials

1

Competitors

Pipeline

Status by Indication[3][1]

Indication

DepressedTerminated

DepressedPreclinical

Terminated

Competition

Competitive Landscape

2 competitors in Depressed

#DrugCompanyPhaseTrials

Pregnenolone

VVA Office of Research and Development

sertraline or amitriptyline

GGerman Research Foundation

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Depressed1 trial

Interpersonal Psychotherapy for Severely Depressed Inpatients

Terminated·GGerman Research Foundation·N/A·NCT00325000

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for sertraline or amitriptyline. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — sertraline or amitriptyline compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for sertraline or amitriptyline. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — German Research Foundation company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: GGerman Research Foundation

Related News